Literature DB >> 647888

A case-control study of regular aspirin use and coronary deaths.

C H Hennekens, L K Karlson, B Rosner.   

Abstract

Information was collected for a large number of coronary risk factors on a series of 568 married, white men, aged 30--70 years, who died from coronary heart disease. Information on the same risk factors was collected on an equal number of living controls matched on age, sex, marital status and neighborhood. For regular aspirin users (i.e. greater than or equal to 4 days per week) compared with non-users, the crude matched pair risk ratio estimate was 1.0 (95% confidence limits 0.9--1.1). Even after controlling for possible confounding effects of other variables using a paired multiple logistic regression analysis, there was no evidence of association. These data provide no evidence for a preventive role of regular aspirin intake in coronary deaths.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 647888     DOI: 10.1161/01.cir.58.1.35

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

Review 1.  Prevention of cardiovascular disease: risks and benefits of aspirin.

Authors:  J E Buring; C H Hennekens
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

Review 2.  Treatment and prevention of cardiovascular disease by aspirin.

Authors:  C H Hennekens
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

Review 3.  The current role of platelet-active drugs in ischaemic heart disease.

Authors:  D M Kerins; G A FitzGerald
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

Review 4.  Risk factors, interventions and therapeutic agents in the prevention of atherosclerosis-related ischaemic diseases.

Authors:  M Verstraete
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 5.  Aspirin and cardiovascular disease.

Authors:  C H Hennekens; J E Buring
Journal:  Bull N Y Acad Med       Date:  1989-01

6.  Aspirin use is associated with an improved long-term survival in an unselected population presenting with unstable angina.

Authors:  Louai Razzouk; Verghese Mathew; Ryan J Lennon; Ashish Aneja; Joshua I Mozes; Heather J Wiste; Paul Muntner; James H Chesebro; Michael E Farkouh
Journal:  Clin Cardiol       Date:  2010-09       Impact factor: 2.882

7.  Aspirin and myocardial infarction in young women.

Authors:  L Rosenberg; D Slone; S Shapiro; D W Kaufman; O S Miettinen; P D Stolley
Journal:  Am J Public Health       Date:  1982-04       Impact factor: 9.308

8.  Plasma levels of aspirin following effervescent and enteric coated tablets, and their effect on platelet function.

Authors:  L M Ross-Lee; M J Elms; B E Cham; F Bochner; I H Bunce; M J Eadie
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 9.  Antiplatelet drugs: clinical pharmacology and therapeutic use.

Authors:  A S Gallus
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546

10.  A corpus of potentially contradictory research claims from cardiovascular research abstracts.

Authors:  Abdulaziz Alamri; Mark Stevenson
Journal:  J Biomed Semantics       Date:  2016-06-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.